Vir Biotechnology, Inc. (VIR) Free cash flow 2017–2025
Vir Biotechnology, Inc. (VIR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$396.6MFY2025 · since FY2017: -$69.1M → -$396.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$396.6M | +12.6% |
| FY2024 | -$453.7M | +43.3% |
| FY2023 | -$800.4M | -150.2% |
| FY2022 | $1.6B | +2398.4% |
| FY2021 | -$69.4M | +64.9% |
| FY2020 | -$197.5M | -42.5% |
| FY2019 | -$138.6M | -35.5% |
| FY2018 | -$102.3M | -48.0% |
| FY2017 | -$69.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice